查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942595

2026年全球先天性心臟疾病器材市場報告

Congenital Heart Defect Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，先天性心臟疾病器材市場發展迅速，預計將以7.4%的複合年成長率成長，從2025年的31.1億美元成長到2026年的33.4億美元。過去幾年的成長可歸因於多種因素，包括先天性心臟疾病發病率的上升、兒童心臟外科手術的進步、先天性心臟疾病患者生存率的提高、專業心臟護理中心的擴張以及人們對先天性心臟病早期診斷意識的增強。

預計未來幾年，先天性心臟疾病器材市場將維持強勁成長，到2030年市場規模將達到44.5億美元，複合年成長率（CAGR）為7.4%。預測期內的成長要素包括：對早期診斷和治療的日益重視、對微創兒童心臟手術需求的成長、新興市場先進心臟護理服務的普及、先天性心臟疾病成人患者群體的不斷擴大，以及植入式心臟器械技術的持續創新。預測期內的主要趨勢包括：微創先天性心臟病心血管手術的日益普及、經導管和植入式心臟器械的廣泛應用、對嬰兒童心臟介入治療的日益重視、針對複雜心臟缺陷的器械治療的擴展，以及對長期心臟監測和支持設備需求的成長。

先天性心臟疾病器械市場的成長預計將受到微創手術數量不斷增加的推動。這些手術透過微小切口或自然腔道，利用專用器械和技術進行，以最大程度地減少創傷並加快恢復。微創手術數量增加的因素包括技術進步、患者對微創治療的偏好、手術技術的改進以及恢復時間更短、併發症更少等優勢。先天性心臟疾病器械在這些手術中發揮關鍵作用，因為它們能夠透過更小的切口和導管介入的方式對心臟異常進行診斷、治療和管理。例如，根據美國整形外科醫師協會 (ASPS) 的數據，截至 2024 年 6 月，2023 年整形手術數量年增 5%，而微創手術數量較去年同期增加 7%。微創手術的成長反過來又推動了先天性心臟疾病治療器械市場的擴張。

先天性心臟疾病(CHD) 器材市場的主要企業正在加強策略聯盟，以開發創新解決方案。這些聯盟透過匯集資源和專業知識、強化研發、拓展市場覆蓋率以及加速商業化進程，為 CHD 器材領域的公司提供支援。此類合作促進創新，並推動產業成長。例如，2024 年 5 月，總部位於印度的製造公司 Sahajanand Medical Technologies Pvt Ltd (SMT) 與印度醫療技術公司 HeartX 達成合作，旨在改善心血管領域的患者照護。此次合作將使 Sahajanand Medical Technologies (SMT) 能夠透過整合 HeartX 的尖端解決方案（例如 JOVE VB 支架）來增強其在 CHD 市場的地位。此次合作將使 SMT 能夠提供先進的 CHD 器械，從而提高治療效果、簡化手術流程並改善患者預後。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球先天性心臟疾病器材市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 微創先天性心血管手術的普及率不斷提高
    • 經導管和植入式心臟裝置的使用日益增多
    • 越來越重視嬰幼兒兒童的心臟介入治療
    • 擴大以器械為基礎的複雜心臟畸形治療方法
    • 長期心臟監測和輔助設備的需求不斷成長

第5章 終端用戶產業市場分析

  • 醫院
  • 專科心臟診所
  • 兒童心臟病中心
  • 心臟外科中心
  • 學術研究機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球先天性心臟疾病器材市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球先天性心臟疾病器材市場規模、比較及成長率分析
  • 全球先天性心臟疾病器材市場表現：規模與成長，2020-2025年
  • 全球先天性心臟疾病器材市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依設備類型
  • 導管、心律調節器、植入式心臟整流去顫器、植入式心臟循環記錄器和其他裝置類型
  • 按缺陷類型
  • 心房中膈缺損症、室間隔缺損、房室間隔缺損、三尖瓣閉鎖、動脈幹畸形及其他類型的缺損
  • 最終用戶
  • 醫院、專科診所、學術研究機構和其他最終用戶
  • 按類型細分：導管
  • 球囊導管、診斷導管、引導管
  • 按類型細分：心臟心律調節器
  • 單腔心律調節器、雙腔心律調節器、雙心室節律器、無導線心律調節器
  • 依類型細分：植入式心臟整流去顫器
  • 單腔ICD、雙腔ICD、皮下ICD
  • 依類型細分：雙心室裝置
  • CRT-P（心臟再同步治療心律調節器）、CRT-D（心臟再同步治療去心房顫動）
  • 按類型細分：植入式心臟循環記錄儀
  • 傳統植入式循環記錄儀，皮下植入式循環記錄儀
  • 按類型細分：其他設備類型
  • 經導管心臟瓣膜、心室輔助裝置（VADS）

第10章 區域與國家分析

  • 全球先天性心臟疾病器材市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球先天性心臟疾病器材市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 先天性心臟疾病器材市場：競爭格局及市場佔有率（2024年）
  • 先天性心臟疾病器材市場：公司估值矩陣
  • 先天性心臟疾病器材市場：公司概況
    • Johnson & Johnson
    • Abbott Laboratories
    • Medtronic plc
    • Boston Scientific Corporation
    • WL Gore & Associates Inc

第37章：其他領先和創新企業

  • Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年先天性心臟疾病器材市場：提供新機會的國家
  • 2030年先天性心臟疾病器材市場：充滿新機會的細分市場
  • 2030年先天性心臟疾病器材市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MCHDD01_G26Q1

Congenital heart defect devices are specialized medical instruments and implants designed to address and manage heart abnormalities present from birth. These devices are used to diagnose, treat, and support the heart's function in individuals with congenital heart defects, aiming to restore normal blood flow and enhance cardiac performance.

The primary types of congenital heart defect devices include catheters, pacemakers (single-chamber, dual-chamber, biventricular, and leadless), implantable cardioverter defibrillators, biventricular devices, and implanted cardiac loop recorders. Catheters are slender, flexible tubes inserted into the body for various functions such as diagnostic, therapeutic, or monitoring purposes. These devices are used for different types of congenital defects, including ventricular septal defect, atrioventricular septal defect, tricuspid atresia, truncus arteriosus, and others. They are employed by hospitals, specialty clinics, academic and research institutions, and other healthcare settings.

Tariffs are impacting the congenital heart defect devices market by increasing costs for imported medical-grade materials, electronic components, and precision-engineered parts used in pacemakers, catheters, and implantable cardiac devices. These cost pressures have particularly affected advanced implantable and transcatheter device segments, with north america and europe experiencing higher exposure due to complex global supply chains. Increased tariffs have raised procurement costs for hospitals and specialty clinics. However, tariffs have also encouraged localized manufacturing, supplier diversification, and regional production expansion, strengthening long-term supply chain resilience.

The congenital heart defect devices market research report is one of a series of new reports from The Business Research Company that provides congenital heart defect devices market statistics, including congenital heart defect devices industry global market size, regional shares, competitors with a congenital heart defect devices market share, detailed congenital heart defect devices market segments, market trends and opportunities, and any further data you may need to thrive in the congenital heart defect devices industry. This congenital heart defect devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congenital heart defect devices market size has grown strongly in recent years. It will grow from $3.11 billion in 2025 to $3.34 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising incidence of congenital heart defects, advancements in pediatric cardiac surgery, increasing survival rates of congenital heart patients, expansion of specialized cardiac care centers, growing awareness of early congenital defect diagnosis.

The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $4.45 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing focus on early diagnosis and intervention, rising demand for minimally invasive pediatric cardiac treatments, expanding access to advanced cardiac care in emerging markets, growing population of adults with congenital heart disease, continuous innovation in implantable cardiac devices. Major trends in the forecast period include rising adoption of minimally invasive congenital heart procedures, increasing use of transcatheter and implantable cardiac devices, growing focus on early-life and pediatric cardiac interventions, expansion of device-based therapies for complex heart defects, increasing demand for long-term cardiac monitoring and support devices.

The growth of the congenital heart defect device market is anticipated to be driven by the rising number of minimally invasive procedures. These procedures involve performing surgeries through small incisions or natural body openings, using specialized tools and techniques to minimize trauma and improve recovery. Factors contributing to the increase in minimally invasive procedures include technological advancements, patient preference for less invasive treatments, enhanced surgical techniques, and the advantages of reduced recovery times and complications. Congenital heart defect devices play a crucial role in these procedures by enabling the diagnosis, treatment, and management of heart abnormalities through smaller incisions or catheter-based approaches. For example, in June 2024, according to the American Society of Plastic Surgeons, a US-based organization, plastic surgeries in 2023 increased by 5%, while minimally invasive procedures grew by 7% compared to the previous year. This rise in minimally invasive procedures is consequently boosting the congenital heart defect device market.

Major players in the congenital heart defect (CHD) devices market are increasingly forming strategic partnerships to develop innovative solutions. These partnerships help companies in the CHD devices sector by combining resources and expertise, enhancing research and development efforts, expanding market reach, and accelerating the commercialization process. Such collaborations foster innovation and contribute to industry growth. For example, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, entered into a partnership with HeartX, an India-based MedTech firm, to improve patient care in the cardiovascular sector. Through this collaboration, Sahajanand Medical Technologies (SMT) strengthens its presence in the CHD market by incorporating HeartX's cutting-edge solutions, such as the JOVE VB Stent. This alliance enables SMT to provide advanced CHD devices that improve treatment effectiveness, simplify procedures, and enhance patient outcomes.

In June 2023, Translumina Therapeutics LLP, an India-based cardiovascular device manufacturer, acquired Wellinq Group Company for an undisclosed sum. This acquisition aims to broaden Translumina's cardiovascular and endovascular solutions portfolio and strengthen its market presence in the Netherlands by integrating Blue Medical Devices' innovative technologies and expertise. Wellinq Group Company, based in the Netherlands, specializes in developing and manufacturing products for treating congenital heart defects.

Major companies operating in the congenital heart defect devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc

North America was the largest region in the congenital heart defect devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart defect devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The congenital heart defect devices market consists of sales of septal occluders, heart valves, patent ductus arteriosus (PDA) devices, and bioprosthetic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congenital Heart Defect Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses congenital heart defect devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congenital heart defect devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The congenital heart defect devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Device Type: Catheters; Pacemakers; Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers; Implantable Cardioverter Defibrillators; Biventricular Devices; Implanted Cardiac Loop Recorders; Other Device Types
  • 2) By Defect Type: Atrial Septal Defect; Ventricular Septal Defect; Atrioventricular Septal Defect; Tricuspid Atresia; Truncus Arteriosus; Other Defect Types
  • 3) By End user: Hospitals; Specialty Clinics; Academic And Research Institute; Other End Users
  • Subsegments:
  • 1) By Catheters: Balloon Catheters; Diagnostic Catheters; Guiding Catheters
  • 2) By Pacemakers: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers
  • 3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds; Dual-Chamber Icds; Subcutaneous Icds
  • 4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers); Crt-D (Cardiac Resynchronization Therapy Defibrillators)
  • 5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders; Subcutaneous Implantable Loop Recorders
  • 6) By Other Device Types: Transcatheter Heart Valves; Ventricular Assist Devices (VADS)
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; W L Gore & Associates Inc; Lepu Medical Technology Beijing Co Ltd; MicroPort Scientific Corporation; Berlin Heart GmbH; Syncardia Systems LLC; Occlutech Holding AG; Sahajanand Medical Technologies Pvt Ltd; Xeltis AG; Procyrion Inc; Heartstitch Inc; Cardia Inc; OSYPKA Medical GmbH; On-X Life Technologies Inc; Ventracor Limited; HemoFlow Technologies; NuPulseCV Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Congenital Heart Defect Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Congenital Heart Defect Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Congenital Heart Defect Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Congenital Heart Defect Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Minimally Invasive Congenital Heart Procedures
    • 4.2.2 Increasing Use Of Transcatheter And Implantable Cardiac Devices
    • 4.2.3 Growing Focus On Early-Life And Pediatric Cardiac Interventions
    • 4.2.4 Expansion Of Device-Based Therapies For Complex Heart Defects
    • 4.2.5 Increasing Demand For Long-Term Cardiac Monitoring And Support Devices

5. Congenital Heart Defect Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Specialty Cardiac Clinics
  • 5.3 Pediatric Cardiology Centers
  • 5.4 Cardiac Surgery Centers
  • 5.5 Academic And Research Institutes

6. Congenital Heart Defect Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Congenital Heart Defect Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Congenital Heart Defect Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Congenital Heart Defect Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Congenital Heart Defect Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Congenital Heart Defect Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Congenital Heart Defect Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Congenital Heart Defect Devices Market Segmentation

  • 9.1. Global Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Catheters, Pacemakers, Implantable Cardioverter Defibrillators, Biventricular Devices, Implanted Cardiac Loop Recorders, Other Device Types
  • 9.2. Global Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect, Tricuspid Atresia, Truncus Arteriosus, Other Defect Types
  • 9.3. Global Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialty Clinics, Academic And Research Institute, Other End Users
  • 9.4. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Balloon Catheters, Diagnostic Catheters, Guiding Catheters
  • 9.5. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers
  • 9.6. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Chamber Icds, Dual-Chamber Icds, Subcutaneous Icds
  • 9.7. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Biventricular Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Crt-P (Cardiac Resynchronization Therapy Pacemakers), Crt-D (Cardiac Resynchronization Therapy Defibrillators)
  • 9.8. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implanted Cardiac Loop Recorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Traditional Implantable Loop Recorders, Subcutaneous Implantable Loop Recorders
  • 9.9. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transcatheter Heart Valves, Ventricular Assist Devices (VADS)

10. Congenital Heart Defect Devices Market Regional And Country Analysis

  • 10.1. Global Congenital Heart Defect Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Congenital Heart Defect Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Congenital Heart Defect Devices Market

  • 11.1. Asia-Pacific Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Congenital Heart Defect Devices Market

  • 12.1. China Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Congenital Heart Defect Devices Market

  • 13.1. India Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Congenital Heart Defect Devices Market

  • 14.1. Japan Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Congenital Heart Defect Devices Market

  • 15.1. Australia Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Congenital Heart Defect Devices Market

  • 16.1. Indonesia Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Congenital Heart Defect Devices Market

  • 17.1. South Korea Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Congenital Heart Defect Devices Market

  • 18.1. Taiwan Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Congenital Heart Defect Devices Market

  • 19.1. South East Asia Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Congenital Heart Defect Devices Market

  • 20.1. Western Europe Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Congenital Heart Defect Devices Market

  • 21.1. UK Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Congenital Heart Defect Devices Market

  • 22.1. Germany Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Congenital Heart Defect Devices Market

  • 23.1. France Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Congenital Heart Defect Devices Market

  • 24.1. Italy Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Congenital Heart Defect Devices Market

  • 25.1. Spain Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Congenital Heart Defect Devices Market

  • 26.1. Eastern Europe Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Congenital Heart Defect Devices Market

  • 27.1. Russia Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Congenital Heart Defect Devices Market

  • 28.1. North America Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Congenital Heart Defect Devices Market

  • 29.1. USA Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Congenital Heart Defect Devices Market

  • 30.1. Canada Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Congenital Heart Defect Devices Market

  • 31.1. South America Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Congenital Heart Defect Devices Market

  • 32.1. Brazil Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Congenital Heart Defect Devices Market

  • 33.1. Middle East Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Congenital Heart Defect Devices Market

  • 34.1. Africa Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Congenital Heart Defect Devices Market Regulatory and Investment Landscape

36. Congenital Heart Defect Devices Market Competitive Landscape And Company Profiles

  • 36.1. Congenital Heart Defect Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Congenital Heart Defect Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Congenital Heart Defect Devices Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. W L Gore & Associates Inc Overview, Products and Services, Strategy and Financial Analysis

37. Congenital Heart Defect Devices Market Other Major And Innovative Companies

  • Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc

38. Global Congenital Heart Defect Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Congenital Heart Defect Devices Market

40. Congenital Heart Defect Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Congenital Heart Defect Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Congenital Heart Defect Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Congenital Heart Defect Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer